No Data
No Data
Guangdong Transtek Medical Electronics (300562.SZ): Accelerate the commercial application of digital chronic disease services, achieving the "second growth curve" through "device + AI Software + Medical Services."
Gelonghui, on December 27, announced that Guangdong Transtek Medical Electronics (300562.SZ) stated during an investor relations event that, first, in terms of business development: the company will actively enhance the comprehensive competitiveness of its products through research and development innovation, by developing potential needs of existing customers and further exploring new customers and new demands to increase market share overseas. At the same time, it will provide Asia Vets health monitoring products for domestic and international well-known health monitoring device industry clients to further open up the domestic market. Secondly, in terms of product innovation: the company will continue to increase its investment in research and development for digital chronic disease management, achieve product innovation and technological innovation, and launch new products. The company will promote its smart health...
Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Soars 36% But It's A Story Of Risk Vs Reward
Guangdong Transtek Medical Electronics Co., Ltd's (SZSE:300562) Market Cap Rose CN¥606m Last Week; Individual Investors Who Hold 54% Profited and so Did Insiders
guangdong transtek medical electronics (300562.SZ): The extension of the medical instruments production license applied by Richco Healthcare has been approved.
Gelonghui, November 18 - Guangdong Transtek Medical Electronics (300562.SZ) announced that its holding subsidiary, Shenzhen Ruikang Hongye Technology Development Co., Ltd. (hereinafter referred to as "Ruikang Hongye" or "subsidiary"), recently received the "Medical Instruments Production License" issued by the Guangdong Provincial Pharmaceutical Supervision Administration (License No.: Yue Shi Yao Jian Xie Sheng Chan Xu 20142566). It has been learned that the application for the continuation of the medical instruments production license by Ruikang Hongye has been approved.
Lexin Healthcare: Report for the third quarter of 2024
Guangdong Transtek Medical Electronics (300562.SZ): Lepu OTC hearing aids have achieved innovative functions such as adaptive hearing tests, automatic adaptation, and user hearing data tracking.
格隆汇October 16th | guangdong transtek medical electronics (300562.SZ) stated in the investor relations that the company focuses on the digital chronic disease management sector, deeply integrating health IoT, big data, AI, and medical services, accelerating the commercial application of cardiovascular digital chronic disease services. Currently, the main directions of AI technology application are: (1) Applied to medical diagnosis: mainly in the remote electrocardiogram service sector - dynamic electrocardiogram diagnosis (self-developed AI algorithm), innovative wearable electrocardiographic devices as carriers, leading AI algorithms as pioneers, focusing on solving critical diseases such as heart disease, stroke, etc.